郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价In vitro pharmacology of fentanyl analogs at the human mu opioid receptor and their spectroscopic analysis.

期刊：Drug testing and analysis发表年份：2020作者：Sherif H Hassanien; Jonathon R Bassman; Carmelita M Perrien Naccarato; Jack J Twarozynski; John R Traynor; Donna M Iula; Jessica P Anand
阅读更多 →

药效评价Identification and characterization of plant-derived alkaloids, corydine and corydaline, as novel mu opioid receptor agonists.

期刊：Scientific reports发表年份：2020作者：Teresa Kaserer; Theresa Steinacher; Roman Kainhofer; Filippo Erli; Sonja Sturm; Birgit Waltenberger; Daniela Schuster; Mariana Spetea
阅读更多 →

药效评价Discovery of an Inhibitor for the TREK-1 Channel Targeting an Intermediate Transition State of Channel Gating.

期刊：Journal of medicinal chemistry发表年份：2020作者：Yuqin Ma; Qichao Luo; Jie Fu; Yanxin Che; Fei Guo; Lianghe Mei; Qiansen Zhang; Yang Li; Huaiyu Yang
阅读更多 →

药效评价Characterization of Neurons Expressing the Novel Analgesic Drug Target Somatostatin Receptor 4 in Mouse and Human Brains.

期刊：International journal of molecular sciences发表年份：2020作者：Angéla Kecskés; Krisztina Pohóczky; Miklós Kecskés; Zoltán V Varga; Viktória Kormos; Éva Szőke; Nóra Henn-Mike; Máté Fehér; József Kun; Attila Gyenesei; Éva Renner; Miklós Palkovits; Péter Ferdinandy; István M Ábrahám; Balázs Gaszner; Zsuzsanna Helye
阅读更多 →